AHL Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.18M | Sell |
34,298
-45,606
| -57% | -$1.57M | 0.02% | 846 |
|
|
2017
Q3 | $2.89M | Buy |
79,904
+29,753
| +59% | +$1.08M | 0.05% | 552 |
|
|
2017
Q2 | $1.3M | Sell |
50,151
-28,760
| -36% | -$743K | 0.03% | 712 |
|
|
2017
Q1 | $1.52M | Buy |
78,911
+14,818
| +23% | +$284K | 0.03% | 687 |
|
|
2016
Q4 | $1.07M | Buy |
64,093
+29,888
| +87% | +$498K | 0.03% | 654 |
|
|
2016
Q3 | $704K | Buy |
34,205
+18,366
| +116% | +$378K | 0.03% | 698 |
|
|
2016
Q2 | $485K | Buy |
15,839
+7,798
| +97% | +$239K | 0.03% | 615 |
|
|
2016
Q1 | $301K | Sell |
8,041
-52,541
| -87% | -$1.97M | 0.02% | 671 |
|
|
2015
Q4 | $2.62M | Buy |
60,582
+50,117
| +479% | +$2.16M | 0.2% | 182 |
|
|
2015
Q3 | $392K | Sell |
10,465
-141,097
| -93% | -$5.29M | 0.06% | 471 |
|
|
2015
Q2 | $5.15M | Sell |
151,562
-1,384
| -0.9% | -$47K | 0.21% | 165 |
|
|
2015
Q1 | $5.41M | Buy |
152,946
+81,593
| +114% | +$2.89M | 0.22% | 141 |
|
|
2014
Q4 | $2.43M | Buy |
71,353
+60,742
| +572% | +$2.07M | 0.13% | 367 |
|
|
2014
Q3 | $409K | Buy |
+10,611
| New | +$409K | 0.03% | 530 |
|